These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 38249351)

  • 1. Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis.
    Tan Y; Zhang Z; Zhou P; Zhang Q; Li N; Yan Q; Huang L; Yu J
    Front Pharmacol; 2023; 14():1288159. PubMed ID: 38249351
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy of seven Chinese patent medicines for early diabetic kidney disease: A Bayesian network meta-analysis.
    Zhao J; Ai J; Mo C; Shi W; Meng L
    Complement Ther Med; 2022 Aug; 67():102831. PubMed ID: 35398481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy, safety, and cost of nine Chinese patent medicines combined with ACEI/ARB in the treatment of early diabetic kidney disease: A network meta-analysis.
    Liu J; Zhang X; Xu G
    Front Pharmacol; 2022; 13():939488. PubMed ID: 36071841
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of Ophiocordyceps sinensis combined with ACEI/ARB on diabetic kidney disease: A systematic review and meta-analysis.
    Yan G; Chang T; Zhao Y; Yu M; Mi J; Wang G; Wang X; Liao X
    Phytomedicine; 2023 Jan; 108():154531. PubMed ID: 36375237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Keluoxin capsule in combination with Western medicine for diabetic kidney disease: A systematic review and meta-analysis.
    Zhang W; Zhou J; Wang C; Wang X; Zhang S; Jia W; Jiang Y; Lin L; Gong Y
    Front Pharmacol; 2022; 13():1052852. PubMed ID: 36686708
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of
    Zhou P; Hao Z; Xu W; Zhou X; Yu J
    Front Pharmacol; 2022; 13():936678. PubMed ID: 36172199
    [No Abstract]   [Full Text] [Related]  

  • 8. The Effectiveness and Safety of
    Jia Q; Guo J; Cai Y; Huang W; Zhu Z; Xia C; Guo K; Shang H; Liu Y; Liu W
    Evid Based Complement Alternat Med; 2022; 2022():9730753. PubMed ID: 36248420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Ophiocordyceps sinensis (syn. Cordyceps sinensis) combined with angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) versus ACEI/ARB alone in the treatment of diabetic kidney disease: a meta-analysis.
    Luo Y; Yang SK; Zhou X; Wang M; Tang D; Liu FY; Sun L; Xiao L
    Ren Fail; 2015 May; 37(4):614-34. PubMed ID: 25682973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis.
    Feng Y; Huang R; Kavanagh J; Li L; Zeng X; Li Y; Fu P
    Am J Cardiovasc Drugs; 2019 Jun; 19(3):259-286. PubMed ID: 30737754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of Salvia miltiorrhiza (Salvia miltiorrhiza Bunge) and ligustrazine injection in the adjuvant treatment of early-stage diabetic kidney disease: A systematic review and meta-analysis.
    Xie F; Zhang B; Dai S; Jin B; Zhang T; Dong F
    J Ethnopharmacol; 2021 Dec; 281():114346. PubMed ID: 34153447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional Chinese medicine for the treatment of diabetic kidney disease: A study-level pooled analysis of 44 randomized controlled trials.
    Liu X; Ge M; Zhai X; Xiao Y; Zhang Y; Xu Z; Zhou Z; Mei Z; Yang X
    Front Pharmacol; 2022; 13():1009571. PubMed ID: 36313382
    [No Abstract]   [Full Text] [Related]  

  • 13. Pentoxifylline for diabetic kidney disease.
    Shan D; Wu HM; Yuan QY; Li J; Zhou RL; Liu GJ
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006800. PubMed ID: 22336824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
    Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of the traditional Chinese formula Shengjiang powder combined with conventional therapy in the treatment of diabetic kidney disease: a systematic review and meta-analysis.
    Zhang Z; Liu Y; Qian J; Jiang W; Cao L; Li Z; Chen H; Liu S
    Front Endocrinol (Lausanne); 2024; 15():1400939. PubMed ID: 39109075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of Tongmai Jiangtang capsule combined with conventional therapy in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis.
    Sun LX; Li YY; Xie YM
    Front Neurol; 2023; 14():1100327. PubMed ID: 37181570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: A systematic review and network meta-analysis.
    Zhang L; Miao R; Yu T; Wei R; Tian F; Huang Y; Tong X; Zhao L
    Pharmacol Res; 2022 Mar; 177():106111. PubMed ID: 35183713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of Niaoduqing granules in the treatment of diabetic kidney disease: a systematic review and meta-analysis.
    Song C; Zhu Z; Liu L; Liu S; Li Y; Xiao Y; Wu C; Nan Z
    Front Pharmacol; 2023; 14():1180751. PubMed ID: 37475716
    [No Abstract]   [Full Text] [Related]  

  • 20.
    Shi L; Feng L; Zhang M; Li X; Yang Y; Zhang Y; Ni Q
    Evid Based Complement Alternat Med; 2019; 2019():9679234. PubMed ID: 31118973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.